FDA told an Illinois-based compounding pharmacy earlier this week that it no longer stands by an enforcement discretion policy laid out in 2005 that allowed the company to link patients to prescriptions after the compounded product was shipped to hospitals, rather than requiring an individual prescription in advance.
Subscription required here
No comments:
Post a Comment